James, N. D., Tannock, I., N’Dow, J., Feng, F., Gillessen, S., Ali, S. A., … Xie, L.-P. (2024). The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet, 403(10437), 1683–1722. https://doi.org/10.1016/S0140-6736(24)00651-2

James, Nicholas D., Ian Tannock, James N’Dow, Felix Feng, Silke Gillessen, Syed Adnan Ali, Blanca Trujillo, et al. “The Lancet Commission on prostate cancer: planning for the surge in cases.” Lancet 403, no. 10437 (April 27, 2024): 1683–1722. https://doi.org/10.1016/S0140-6736(24)00651-2.

James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024 Apr 27;403(10437):1683–722.

James, Nicholas D., et al. “The Lancet Commission on prostate cancer: planning for the surge in cases.” Lancet, vol. 403, no. 10437, Apr. 2024, pp. 1683–722. Pubmed, doi:10.1016/S0140-6736(24)00651-2.

James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, Trujillo B, Al-Lazikani B, Attard G, Bray F, Compérat E, Eeles R, Fatiregun O, Grist E, Halabi S, Haran Á, Herchenhorn D, Hofman MS, Jalloh M, Loeb S, MacNair A, Mahal B, Mendes L, Moghul M, Moore C, Morgans A, Morris M, Murphy D, Murthy V, Nguyen PL, Padhani A, Parker C, Rush H, Sculpher M, Soule H, Sydes MR, Tilki D, Tunariu N, Villanti P, Xie L-P. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024 Apr 27;403(10437):1683–1722.